Related Experiment Video

Updated: May 6, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.1K

MicroRNA-gene signaling pathways in pancreatic cancer

Alexandra Drakaki1, Dimitrios Iliopoulos

  • 1Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.

Biomedical Journal
|November 15, 2013
PubMed

Insights

MicroRNAs regulate key signaling pathways in pancreatic cancer, offering potential for new therapies. Targeting these microRNAs could overcome treatment resistance and improve patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Pancreatic cancer is a leading cause of cancer death, marked by early metastasis and resistance to standard treatments.
  • Current therapies, including gemcitabine, offer limited survival benefits, highlighting the need for novel therapeutic strategies.
  • Understanding the molecular mechanisms driving pancreatic cancer is crucial for developing effective treatments.

Purpose of the Study:

  • To elucidate the role of microRNAs in controlling signaling pathways deregulated in pancreatic cancer.
  • To explore the potential of microRNAs as therapeutic agents for pancreatic cancer.
  • To identify central regulators of pancreatic oncogenesis for targeted therapy development.

Main Methods:

  • Review and analysis of microRNA involvement in pancreatic cancer signaling pathways.
  • Evaluation of microRNAs' potential to reverse chemo- and radio-resistance.
  • Integration of deregulated genes and microRNAs into molecular networks.

Main Results:

  • MicroRNAs are key regulators of signaling pathways frequently altered in pancreatic cancer.
  • MicroRNAs demonstrate potential in overcoming chemo- and radio-resistance.
  • Identifying central regulators within molecular networks is essential for targeted therapies.

Conclusions:

  • MicroRNAs represent promising therapeutic targets for pancreatic cancer.
  • Targeting microRNAs could lead to novel treatment strategies overcoming drug resistance.
  • Further research into molecular networks is needed to identify key regulators for novel therapeutic approaches.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.3K
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

24.0K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
MicroRNAs01:22

MicroRNAs

9.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K